Fresco-2: A Global Phase Iii Study Of The Efficacy And Safety Of Fruquintinib In Patients (Pts) With Metastatic Colorectal Cancer (Mcrc).

Arvind Dasari,James C. Yao,Alberto F. Sobrero,Takayuki Yoshino,William R. Schelman,Shivani Nanda,Caly Chien, Su-Fen Pu,Marek K. Kania,Josep Tabernero,Cathy Eng

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 4|浏览0

暂无评分

摘要

TPS154Background: Pts with mCRC have limited treatment options following progression on standard therapies. Current standard of care (SOC) after pts progress on trifluridine/tipiracil (TAS-102) or ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要